Led by CB Insights Senior Intelligence Analyst, Marissa Schlueter
This webinar provides an update on global healthcare funding and investments in Q1’20 in the shadow of the COVID-19 pandemic.
Marissa walks you through the findings in our recently-released State Of Healthcare Report and demonstrates how she uses the CB Insights Emerging Technology Insights Platform to uncover global healthcare trends and track funding activity in real time.
Download the slides and recording to find out:
- How COVID-19 is impacting deal activity in China
- Why funding for North American healthcare startups hit an all-time high of $10.3B in Q1
- Why the medical device, infectious disease, and life-support markets dominated investment activity in Q1
Marissa is a Senior Intelligence Analyst at CB Insights, where she produces data-driven analysis and research reports on trends in the healthcare industry — with a specific focus on medical devices, telehealth, and cannabis.
Prior to joining CB Insights, Marissa worked as an equity research analyst at Melius Research and as an institutional equity salesperson at Barclays. She graduated with honors from Princeton University with a degree in Molecular Biology, and is currently pursuing MBA+MS degrees through Johns Hopkins University, with concentrations in Health Care Management and Biotechnology Enterprise. Marissa is a CFA Charterholder.